Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells
Biaolong Yang(Shanghai Changzheng Hospital), Yuan‐Sheng Zang(Second Military Medical University)
Cited by 18
Related Papers
The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer
|Critical Reviews in Oncology/Hematology|2020|71